Factor concentrates for the treatment of factor XIII deficiency

Current Opinion in Hematology

Volumn 5, Issue 6, 1998, Pages 372-375

  Gootenberg, Joseph E ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BLEEDING DISORDER; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BRAIN HEMORRHAGE; CASE REPORT; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; NEWBORN; PRIORITY JOURNAL;

EID: 0031743817     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199811000-00003     Document Type: Article

References (27)

1. Duckert F, Jung E, Schmerling DH: A hitherto undescribed congenital hemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemaorrh 1960, 5:179-186.
2. Lorand L, Losowsky M, Miloszewski K: Human factor XIII fibrin stabilizing factor. Prog Haemost Thromb 1980, 5:245-290.
3. Adany R: Intracellular Factor XIII: Cellular distribution of factor XIII subunit A in humans. Semin Thromb Hemost 1996, 22:399-408.
4. Muszbak L, Adany R, Mikkola H: Novel aspects of blood coagulation factor XIII. I. Structure, distribution activation, and function. Crit Rev Clin Lab Sci 1996, 33:357-421.
5. Mikkola H, Palotie A: Gene defects in congenital factor XIII deficiency. Semin Thromb Hemost 1996, 22:393-398.
6. Mikkola H, Muszbek L, Laiho E, Syrjala M, Hamalainen E, Haramura G, et al.: Molecular mechanism of a mild phenotype in coagulation factor XIII deficiency: A splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. Blood 1997, 88:1279-1287.
7. Seitz R, Duckert F, Lopaciuk S, Muscbek L, Rodeghiero F, Seligsohn U: ETRO working party on factor XIII questionnaire on congenital factor XIII deficiency in Europe: Status and perspectives. Semin Thromb Hemost 1996, 22:415-418.
8. Board PG, Losowsky MS, Miloszewski JA: Factor XIII: Inherited and acquired deficiency. Blood Rev 1993, 7:229-242.
9. Krumdieck R, Shaw DR, Huang ST, Poon M, Rustagi PK: Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenstrom's macroglobulinemia. Am J Med 1991, 90:639-645.
10. Tosetto A, Rodeghiero F, Gatto E, Manotti C, Poli T: An acquired hemorrhagic disorder of fibrin crosslinking due to IgG antibodies to factor XIII, successfully treated with factor XIII replacement and cyclophosphamide. Am J Hematol 1995, 48:34-39.
11. Daly HM, Carson PJ, Smith JK: Intracerebral hemorrhage due to acquired factor XIII inhibitor-successful response to factor XIII concentrate. Blood Coagul Fibrinolysis 1991, 2:507-514.
12. Scott-Timperely LJ, Haire WD: Autoimmune coagulation disorders. Rheum Dis Clin North Am 1997, 23:411-423.
13. Kitchens CS, Newcomb TF: Factor XIII. Medicine (Baltimore) 1979, 58:413-429.
14. Rodeghiero R, Castaman GC, DiBona E, Ruggeri M, Dini E: Successful pregnancy in a woman with congenital Factor XIII deficiency treated with substitutive therapy. Blut 1987, 55:45-48.
15. Kobayashi T, Terao T, Kojima T, Takamatsu J, Kamiya T, Saito H: Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest 1990, 29:235-238.
16. Egbring R, Kroniger A, Seitz R: Factor XIII deficiency: Pathogenetic mechanisms and clinical significance. Semin Thromb Hemostasis 1996, 22:419-425.
17. Abbondanzo SL, Gootenberg JE, Lofts RS, McPherson RA: Intracranial hemorrhage in congenital deficiency of factor XIII. Am J Pediatr Hematol Oncol 1988, 10:65-68.
18. Larsen PD, Wallace JW, Frankel LS, Crisp D: Factor XIII deficiency and intracranial hemorrhages in infancy. Pediatr Neurol 1990, 6:277-278.
19. Duckert F: The fibrin stabilizing factor, factor XIII. Blut 1973, 26:177-199.
20. Karges HE, Metzner HJ: Therapeutic factor XIII preparations and perspectives for recombinant factor XIII. Semin Thromb Hemost 1996, 22:427-436.
21. Brackmann HH, Egbring R, Ferster A, Fondu P, Girardel JM, Kreuz W, et al.: Pharmacokinetics and tolerability of factor XIII concentrates prepared from human placenta or plasma: A crossover randomized study. Thromb Haemost 1995, 74:622-625.
22. Daly HM, Haddon ME: Clinical experience with a pasteurized human plasma concentrate in factor XIII deficiency. Thromb Haemost 1988, 59:171-174.
23. Winkelman L, Sims GE, Haddon ME, Evans DR, Smith JK: A pasteurized concentrate of human plasma factor XIII for therapeutic use. Thromb Haemost 1986, 55:402-405.
24. Briggs NJ, Harman CT, Gascoigne E: A decade of experience with a factor XIII concentrate. Thromb Haemost 1997, 77(suppl):35-36. This abstract reports 41 patients treated with the plasma-derived factor XIII concentrate produced by BioProducts Laboratory. In 33 patients receiving long-term prophylaxis, treatment was very well tolerated with no evidence of viral transmission.
25. Hilgartner MW, McDonagh J, Gootenberg JE: Experience with Fibrogammin for the long term treatment of congenital factor XIII deficiency in the United States. Blood 1991, 78(suppl 1):60a.
26. Bishop PD, Teller DC, Smith RA, Lasser GN, Gilbert T, Seale RL: Expression, purification and characterization of human factor XIII in Saccharomyces cereviside. Biochem 1990, 29:1861-1869.
27. Metzner HJ, Funt K, Panzer U, Pagves EP: Recombinant factor XIII: Biochemical properties. In Factor XIII: Second International Conference July 1991. Edited by McDonagh J, Seitz R, Egbring R. Stuttgart: Schattauer Verlag: 1993:78-93.